Preparation of a single-chain variable fragment and a recombinant antigen-binding fragment against the anti-malarial drugs, artemisinin and artesunate, and their application in an ELISA

Madan K. Paudel, Ayako Takei, Junichi Sakoda, Thaweesak Juengwatanatrakul, Kaori Sasaki-Tabata, Waraporn Putalun, Yukihiro Shoyama, Hiroyuki Tanaka, Satoshi Morimoto

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Two different recombinant antibodies, a single-chain variable fragment (scFv) and an antigen-binding fragment (Fab), were prepared against artemisinin (AM) and artesunate (AS) and were developed for use in an enzymelinked immunosorbent assay (ELISA). The recombinant antibodies, which were derived from a single monoclonal antibody against AM and AS (mAb 1C1) prepared by us, were expressed by Escherichia coli cells and their reactivity and specificity were characterized. As a result, to obtain sufficient signal in indirect ELISA, a much greater amount of a first antibody was needed in the use of scFv due to the differences of the secondary antibody and conformational stability. Therefore, we focused on the development of the recombinant Fab antibodies and applied it to indirect competitive ELISA. The specificity of the Fab was similar to that of mAb 1C1 in that it showed specific reactivity toward AM and AS only. The sensitivity of the icELISA (0.16 μg/mL to 40 μg/mL for AM and 8.0 ng/mL to 60 ng/mL for AS) was sufficient for analysis of antimalarial drugs, and its utility for quality control of analysis of Artemisia spp. was validated. The Fab expression and refolding systems provided a good yield of high-quality antibodies. The recombinant antibody against AM and AS provides an essential component of an economically attractive immunoassay and will be useful in other immunochemical applications for the analysis and purification of antimalarial drugs.

Original languageEnglish
Pages (from-to)2002-2008
Number of pages7
JournalAnalytical chemistry
Volume84
Issue number4
DOIs
Publication statusPublished - Feb 21 2012

Fingerprint

Single-Chain Antibodies
Immunosorbents
Antimalarials
Assays
Antigens
Antibodies
Pharmaceutical Preparations
Immunoglobulin Fab Fragments
artemisinine
artesunate
Escherichia coli
Purification
Quality control
Monoclonal Antibodies

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry

Cite this

Preparation of a single-chain variable fragment and a recombinant antigen-binding fragment against the anti-malarial drugs, artemisinin and artesunate, and their application in an ELISA. / Paudel, Madan K.; Takei, Ayako; Sakoda, Junichi; Juengwatanatrakul, Thaweesak; Sasaki-Tabata, Kaori; Putalun, Waraporn; Shoyama, Yukihiro; Tanaka, Hiroyuki; Morimoto, Satoshi.

In: Analytical chemistry, Vol. 84, No. 4, 21.02.2012, p. 2002-2008.

Research output: Contribution to journalArticle

Paudel, Madan K. ; Takei, Ayako ; Sakoda, Junichi ; Juengwatanatrakul, Thaweesak ; Sasaki-Tabata, Kaori ; Putalun, Waraporn ; Shoyama, Yukihiro ; Tanaka, Hiroyuki ; Morimoto, Satoshi. / Preparation of a single-chain variable fragment and a recombinant antigen-binding fragment against the anti-malarial drugs, artemisinin and artesunate, and their application in an ELISA. In: Analytical chemistry. 2012 ; Vol. 84, No. 4. pp. 2002-2008.
@article{d9b6b2f16e90444f87ffeaece69382e3,
title = "Preparation of a single-chain variable fragment and a recombinant antigen-binding fragment against the anti-malarial drugs, artemisinin and artesunate, and their application in an ELISA",
abstract = "Two different recombinant antibodies, a single-chain variable fragment (scFv) and an antigen-binding fragment (Fab), were prepared against artemisinin (AM) and artesunate (AS) and were developed for use in an enzymelinked immunosorbent assay (ELISA). The recombinant antibodies, which were derived from a single monoclonal antibody against AM and AS (mAb 1C1) prepared by us, were expressed by Escherichia coli cells and their reactivity and specificity were characterized. As a result, to obtain sufficient signal in indirect ELISA, a much greater amount of a first antibody was needed in the use of scFv due to the differences of the secondary antibody and conformational stability. Therefore, we focused on the development of the recombinant Fab antibodies and applied it to indirect competitive ELISA. The specificity of the Fab was similar to that of mAb 1C1 in that it showed specific reactivity toward AM and AS only. The sensitivity of the icELISA (0.16 μg/mL to 40 μg/mL for AM and 8.0 ng/mL to 60 ng/mL for AS) was sufficient for analysis of antimalarial drugs, and its utility for quality control of analysis of Artemisia spp. was validated. The Fab expression and refolding systems provided a good yield of high-quality antibodies. The recombinant antibody against AM and AS provides an essential component of an economically attractive immunoassay and will be useful in other immunochemical applications for the analysis and purification of antimalarial drugs.",
author = "Paudel, {Madan K.} and Ayako Takei and Junichi Sakoda and Thaweesak Juengwatanatrakul and Kaori Sasaki-Tabata and Waraporn Putalun and Yukihiro Shoyama and Hiroyuki Tanaka and Satoshi Morimoto",
year = "2012",
month = "2",
day = "21",
doi = "10.1021/ac203131f",
language = "English",
volume = "84",
pages = "2002--2008",
journal = "Analytical Chemistry",
issn = "0003-2700",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - Preparation of a single-chain variable fragment and a recombinant antigen-binding fragment against the anti-malarial drugs, artemisinin and artesunate, and their application in an ELISA

AU - Paudel, Madan K.

AU - Takei, Ayako

AU - Sakoda, Junichi

AU - Juengwatanatrakul, Thaweesak

AU - Sasaki-Tabata, Kaori

AU - Putalun, Waraporn

AU - Shoyama, Yukihiro

AU - Tanaka, Hiroyuki

AU - Morimoto, Satoshi

PY - 2012/2/21

Y1 - 2012/2/21

N2 - Two different recombinant antibodies, a single-chain variable fragment (scFv) and an antigen-binding fragment (Fab), were prepared against artemisinin (AM) and artesunate (AS) and were developed for use in an enzymelinked immunosorbent assay (ELISA). The recombinant antibodies, which were derived from a single monoclonal antibody against AM and AS (mAb 1C1) prepared by us, were expressed by Escherichia coli cells and their reactivity and specificity were characterized. As a result, to obtain sufficient signal in indirect ELISA, a much greater amount of a first antibody was needed in the use of scFv due to the differences of the secondary antibody and conformational stability. Therefore, we focused on the development of the recombinant Fab antibodies and applied it to indirect competitive ELISA. The specificity of the Fab was similar to that of mAb 1C1 in that it showed specific reactivity toward AM and AS only. The sensitivity of the icELISA (0.16 μg/mL to 40 μg/mL for AM and 8.0 ng/mL to 60 ng/mL for AS) was sufficient for analysis of antimalarial drugs, and its utility for quality control of analysis of Artemisia spp. was validated. The Fab expression and refolding systems provided a good yield of high-quality antibodies. The recombinant antibody against AM and AS provides an essential component of an economically attractive immunoassay and will be useful in other immunochemical applications for the analysis and purification of antimalarial drugs.

AB - Two different recombinant antibodies, a single-chain variable fragment (scFv) and an antigen-binding fragment (Fab), were prepared against artemisinin (AM) and artesunate (AS) and were developed for use in an enzymelinked immunosorbent assay (ELISA). The recombinant antibodies, which were derived from a single monoclonal antibody against AM and AS (mAb 1C1) prepared by us, were expressed by Escherichia coli cells and their reactivity and specificity were characterized. As a result, to obtain sufficient signal in indirect ELISA, a much greater amount of a first antibody was needed in the use of scFv due to the differences of the secondary antibody and conformational stability. Therefore, we focused on the development of the recombinant Fab antibodies and applied it to indirect competitive ELISA. The specificity of the Fab was similar to that of mAb 1C1 in that it showed specific reactivity toward AM and AS only. The sensitivity of the icELISA (0.16 μg/mL to 40 μg/mL for AM and 8.0 ng/mL to 60 ng/mL for AS) was sufficient for analysis of antimalarial drugs, and its utility for quality control of analysis of Artemisia spp. was validated. The Fab expression and refolding systems provided a good yield of high-quality antibodies. The recombinant antibody against AM and AS provides an essential component of an economically attractive immunoassay and will be useful in other immunochemical applications for the analysis and purification of antimalarial drugs.

UR - http://www.scopus.com/inward/record.url?scp=84858813475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858813475&partnerID=8YFLogxK

U2 - 10.1021/ac203131f

DO - 10.1021/ac203131f

M3 - Article

C2 - 22260329

AN - SCOPUS:84858813475

VL - 84

SP - 2002

EP - 2008

JO - Analytical Chemistry

JF - Analytical Chemistry

SN - 0003-2700

IS - 4

ER -